Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01163578 · ClinicalTrials.gov registry record

Biomarkers in Transplant Recipients to Improve Outcomes

A clinical trial of Bone Marrow Transplantation and Solid Organ Transplantation, sponsored by University of Pittsburgh.

Recruiting
Registry status
1,200
Enrollment target
1
Study location

NCT01163578: Recruiting study of Bone Marrow Transplantation and Solid Organ Transplantation, sponsored by University of Pittsburgh.

NCT01163578 is a study of Bone Marrow Transplantation and Solid Organ Transplantation that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 1,200 participants, above the 113-participant average among 5 other Bone Marrow Transplantation trials with a reported enrollment target (962% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01163578, a study of Bone Marrow Transplantation and Solid Organ Transplantation, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
1,200 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.

Primary Outcome

Biopsy-proven acute cellular rejection

Study Locations (1)

Pennsylvania

  • Children's Hospital of Pittsburgh of UPMC - Pittsburgh

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2005-03
Est. Completion 2030-03
University of Pittsburgh

1,238 total trials

What NCT01163578 shows while recruiting

NCT01163578 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, above the 113-participant average among 5 other Bone Marrow Transplantation trials with a reported enrollment target (962% higher).

The record links to 2 conditions, with Bone Marrow Transplantation appearing as the primary indexed condition, and to 0 interventions.

NCT01163578 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01163578 about?

NCT01163578 is a clinical study titled "Biomarkers in Transplant Recipients to Improve Outcomes". The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.

What is the current status of trial NCT01163578?

This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2005-03. Estimated completion is 2030-03.

What conditions does trial NCT01163578 study?

This clinical trial studies the following conditions: Bone Marrow Transplantation, Solid Organ Transplantation.

Who is sponsoring clinical trial NCT01163578?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01163578 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bone Marrow Transplantation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001987 · 1,200 participants

    Genetic Studies of Insulin and Diabetes

  • NCT00477100 · 1,200 participants

    Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

  • NCT01209000 · 1,200 participants

    Nephrotic Syndrome Study Network

  • NCT01944332 · 1,200 participants · NA

    Gamete Treatment to Correct Fertilization Failure

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01163578, the US trial registry maintained by the National Library of Medicine. NCT01163578 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.